- Home
- BMRA vs NTBL Comparison
BMRA vs NTBL Comparison
Compare BMRA & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- NTBL
- Stock Information
- Founded
- BMRA 1971
- NTBL 2000
- Country
- BMRA United States
- NTBL United States
- Employees
- BMRA N/A
- NTBL N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- NTBL Health Care
- Exchange
- BMRA Nasdaq
- NTBL Nasdaq
- Market Cap
- BMRA 7.4M
- NTBL 4.6M
- IPO Year
- BMRA N/A
- NTBL N/A
- Fundamental
- Price
- BMRA $0.33
- NTBL $0.34
- Analyst Decision
- BMRA
- NTBL Buy
- Analyst Count
- BMRA 0
- NTBL 2
- Target Price
- BMRA N/A
- NTBL $5.00
- AVG Volume (30 Days)
- BMRA 68.2K
- NTBL 8.0M
- Earning Date
- BMRA 10-15-2024
- NTBL 11-12-2024
- Dividend Yield
- BMRA N/A
- NTBL N/A
- EPS Growth
- BMRA N/A
- NTBL N/A
- EPS
- BMRA N/A
- NTBL N/A
- Revenue
- BMRA $5,509,000.00
- NTBL $313,000.00
- Revenue This Year
- BMRA N/A
- NTBL N/A
- Revenue Next Year
- BMRA N/A
- NTBL N/A
- P/E Ratio
- BMRA N/A
- NTBL N/A
- Revenue Growth
- BMRA 1.74
- NTBL 3812.50
- 52 Week Low
- BMRA $0.24
- NTBL $0.22
- 52 Week High
- BMRA $2.13
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- BMRA 47.85
- NTBL 43.04
- Support Level
- BMRA $0.28
- NTBL $0.28
- Resistance Level
- BMRA $0.35
- NTBL $0.67
- Average True Range (ATR)
- BMRA 0.04
- NTBL 0.06
- MACD
- BMRA 0.00
- NTBL -0.00
- Stochastic Oscillator
- BMRA 41.67
- NTBL 27.53
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.